Friday, March 1, 2013

• ALLERGAN INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and ExhibitEDGAR Online (Fri, Mar 1)
• Allergan Becomes #183 Most Shorted S&P 500 Component, Replacing Cablevision Systemsat Forbes (Fri, Mar 1)
• Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form MergerBusiness Wire (Fri, Mar 1)

Thursday, February 28, 2013

• Trade group identifies medical device makers passing on U.S. taxat Reuters (Thu, Feb 28)
• Valeant Earnings, Sales Top Estimates; Street Shrugsat Investor's Business Daily (Thu, Feb 28)

Tuesday, February 26, 2013

• ALLERGAN INC Files SEC form 10-K, Annual ReportEDGAR Online (Tue, Feb 26)
• Allergan Settles Oklahoma Botox Case During Trialat Bloomberg (Tue, Feb 26)
• Valeant Acquires Targretin RightsZacks (Tue, Feb 26)
• Allergan Inc. Stock Buy Recommendation Reiterated (AGN)at TheStreet (Tue, Feb 26)

Monday, February 25, 2013

• Clorox Cleans Up and 3 Stocks Hitting 52-week Highsat Wall St. Cheat Sheet (Mon, Feb 25)
• Allergan Stock To Go Ex-dividend Tomorrow (AGN)at TheStreet (Mon, Feb 25)

Friday, February 22, 2013

• Allergan CEO’s Pay Jumps by Half With $9 Million Stock Awardat Bloomberg (Fri, Feb 22)
• Allergan Ex-Dividend Reminderat Forbes (Fri, Feb 22)

Thursday, February 21, 2013

• Allergan Breast Implant Approved by FDAat Motley Fool (Thu, Feb 21)
• Weight-Loss Surgery Fails to Reduce Costs, Study Findsat Bloomberg (Thu, Feb 21)

Wednesday, February 20, 2013

• FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast ImplantsBusiness Wire (Wed, Feb 20)

Tuesday, February 19, 2013

• Allergan’s Botox Put Boy on Respirator, Lawyer Tells Juryat Bloomberg (Tue, Feb 19)
• Allergan Reaches New 52-Week High (AGN)at TheStreet (Tue, Feb 19)
• Spectrum Pharmaceuticals Earnings: An Early Lookat Motley Fool (Tue, Feb 19)

Friday, February 15, 2013

• Upcoming FDA Approval Decision Dates For Q2 2013at Seeking Alpha (Fri, Feb 15)

Wednesday, February 13, 2013

• 4 Stocks Pushing The Drugs Industry Lowerat TheStreet (Wed, Feb 13)
• The Abbott Labs/AbbVie Split Strategy: Cash Out, Hold, Reinvest?at Seeking Alpha (Wed, Feb 13)

Tuesday, February 12, 2013

• Pharma Buyout With a 60% Premiumat Motley Fool (Tue, Feb 12)
• Allergan Inc. Stock Buy Recommendation Reiterated (AGN)at TheStreet (Tue, Feb 12)

Monday, February 11, 2013

• EnteroMedics May Get Approval, But Will It Get Sales?at Seeking Alpha (Mon, Feb 11)

Add AGN News to My Yahoo!